Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Glaukos Corporation Common Stock (NY:GKOS)

106.74 -2.29 (-2.10%)
Official Closing Price Updated: 4:10 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Glaukos Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Wondering what's happening in today's after-hours session? ↗
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
Earnings Scheduled For February 20, 2025 ↗
 
Via Benzinga
News headline image
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday ↗
 
Via Benzinga
News headline image
Peering Into Glaukos's Recent Short Interest ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Glaukos? ↗
 
Via Benzinga
News headline image
$1000 Invested In Glaukos 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
What 11 Analyst Ratings Have To Say About Glaukos ↗
 
Via Benzinga
News headline image
(GKOS) - Analyzing Glaukos's Short Interest ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Glaukos? ↗
 
Via Benzinga
News headline image
Analyst Scoreboard: 5 Ratings For Glaukos ↗
 
Via Benzinga
News headline image
Short Seller Accuses TransMedics Of 'Mafia Style' Scheme, Organ Transplant Company Says Short Seller Manipulating Market ↗
TransMedics faces allegations from Scorpion Capital of fraud and organ trafficking, while the company rebuffs the claims as baseless market manipulation. 
Via Benzinga
Topics Fraud
News headline image
Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 7 ↗
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 2-6, 2024. 
Via Talk Markets
Topics Stocks / Equities
News headline image
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
 
Via Benzinga
News headline image
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
News headline image
How Is The Market Feeling About Glaukos? ↗
 
Via Benzinga
News headline image
A Closer Look at 7 Analyst Recommendations For Glaukos ↗
 
Via Benzinga
News headline image
This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗
 
Via Benzinga
News headline image
Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds ↗
Glaukos Corporation's Q3 revenue grew 24% to $96.7 million, beating estimates, with an EPS loss of $(0.28). 2024 sales guidance raised despite anticipated headwinds. 
Via Benzinga
News headline image
Navigating 11 Analyst Ratings For Glaukos ↗
 
Via Benzinga
News headline image
Glaukos Stock: A Deep Dive Into Analyst Perspectives (12 Ratings) ↗
 
Via Benzinga
News headline image
Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q2 2024 ↗
GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
10 Analysts Have This To Say About Glaukos ↗
 
Via Benzinga
News headline image
Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings) ↗
 
Via Benzinga
News headline image
7 Leading MedTech Stocks for Next-Gen Health Solutions ↗
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. 
Via InvestorPlace
News headline image
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
 
Via Benzinga
News headline image
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst ↗
Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%. 
Via Benzinga
Topics Earnings
News headline image
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024 ↗
GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.